Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Clinical cure rates
RCT	50 women	Proportion of women with a symptomatic response categorised as 'poor' 14 days 2/25 (8%) with intravaginal nystatin (for 14 days) 10/25 (40%) with placebo	ARR 32% 95% CI 8% to 56% OR 0.18 95% CI 0.05 to 0.65 NNT 3 95% CI 2 to 12	Small effect size	intravaginal nystatin